D.C. Monthly Medical Cannabis Sales: June 2024

Overall program sales fell by more than 13% compared to June 2023. However, Q3 2024 sales eclipsed Q2 by over $1.7 million. Q3 was still lower than Q1 for 2024, and Q3 2024 showed a 14.7% decrease compared to the same period last year.

(Please use a modern browser to see the interactive version of this visualization)

D.C. began recording manufacturer sales separately in its monthly reports in 2023 The sales used to be included in cultivation center sales.

Chart: Outlaw ReportSource: ABCAGet the dataCreated with Datawrapper